TrialPath
Psoriasis · Denver

Psoriasis clinical trials in Denver

1 recruiting psoriasis studies within range of Denver. Click any trial for full eligibility criteria and contact info.

Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis

NCT07286058 · Psoriatic Arthritis
Recruiting

Psoriatic arthritis (PsA) is a long-term inflammatory disease that affects the joints and skin. The purpose of this study is to check how safe zasocitinib is, how well it is tolerated and how well it works in adults with PsA over a longer period of time. Adults who completed the 1-year (52-week) treatment period in one of the parent studies (TAK-279-PsA-3001 \[NCT06671483\] or TAK-279-PsA-3002 \[NCT06671496\]) may be able to join this continuation study (also called long-term extension or LTE study). All participants in this continuation study, will receive zasocitinib (lower or higher dose), once a day (QD). Each participant can be in this study for approximately 2 years (108 weeks). This includes a treatment period of up to 2 years (104 weeks) and a 1-month (4-week) follow-up period to monitor a participant's health.

PhasePhase 3
TypeInterventional
Age18 Years
WhereTucson, Arizona, United States + 110 more
SponsorTakeda
▾Tap for details
Apply